2019 annual financial data
BridgeBio Pharma 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -625.21%.
Operating income was -266,240,000 USD and net income was -260,437,000 USD.
Operating cash flow was -253,587,000 USD.
Get free BridgeBio Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,560,000 USD
- Operating income
- -266,240,000 USD
- Net income
- -260,437,000 USD
- Operating cash flow
- -253,587,000 USD